Eugenics and Equality Can't Mix
Aborting babies with
Eugenics and Equality Can't Mix
Aborting babies with detected disabilities is incompatible with equality.
From the perspective of the disabled and their advocates, we are living in a schizophrenic culture. On the one hand, we are striving to eliminate discrimination and create a society that is welcoming, understanding and inclusive of the largest minority group in the country – a society where having a special need is not a cause for shame and isolation. On the other, we are also a society that goes to great lengths to prevent the birth of the disabled themselves, sharply discriminating against them at their most vulnerable stage.
I am referring, of course, to pre-natal diagnosis with the intent to abort.
Fetal ultrasound has opened a window into the mysteries of early human development and has revolutionized the way we think and feel about pregnancy. "Meeting" one's little girl or boy through the grainy images of the sonogram has become a delightful rite in almost every pregnancy. Unfortunately, it is also a moment when a problem may become apparent: signs of Down's Syndrome, Dwarfism, Cleft Palate or a limb discrepancy. Many times, the presence of a disability or physical defect, or even the possibility of one, drives the parents to "select" against the child. In other words, they abort and "try again."
The number of babies born with disabilities such as Down’s Syndrome has dwindled in America, due to what can fairly be called eugenic abortion. Eugenics is a strong term, and we normally associate it with the depredations of the Nazis, who envisioned the creation of a race of strong and healthy people with no genetic defects. We know what that led them to inflict on humanity. Eugenics is the creation or selection of offspring with "desirable" traits, and the elimination of those that are deemed "deficient." Aborting a child with Dwarfism or Down's would certainly qualify as eugenic.
In this country the practice is widespread and widely accepted. While it is done quietly every day, encouraged by obstetricians scared of a "wrongful life" suit, prominent ethicists are not ashamed of promoting eugenic abortion openly. Peter Singer, ethics professor at Princeton once said, "It does not seem quite wise to increase further drainage of limited resources by increasing the number of children with impairments." The scientist who produced the first successful in-vitro baby, Bob Edwards, predicted "soon it will be a sin of parents to have a child that carries the heavy burden of genetic disease. We are entering a world where we have to consider the quality of our children." This kind of thinking is infecting our culture as prenatal diagnosis becomes ever more effective. Parents of disabled children may feel that they must justify their acceptance of a child who is differently "abled," in an environment where aborting the children is rapidly becoming a duty, not a right.
You might well imagine that people with disabilities are sharply critical of a world-view that would make their very existence a "sin." They themselves value their lives, and suffer their sorrows and delight in their joys, just the same as the "abled." Helen Houghton, a disability advocate, wrote: "The new genetic technologies, including prenatal diagnosis and termination, are inherently a technology of oppression and control, which serve to devalue the lives of people identified as having disabilities." The disabled often contend that it is the discrimination they face at the outset of their lives, as well as socially and in the workplace that is their greatest burden, much more than the disability itself. The disabled would also contend that a child with a disability has the same capacity as an "abled" child to fulfill all the loving dreams and aspirations of his or her parents. Parents who abort are greatly misinformed about the capacity of the disabled to bring their mothers, fathers, and other family members tremendous joy and pride.
A society that wishes (laudably) to eradicate discrimination must address the problem at all levels and in every instance. This is an important ideological challenge to those who champion a "woman's right to choose" as an absolute one, with no boundaries or ethical restrictions. When we do everything in our power to detect the existence of a baby with a special need with the sole purpose of terminating him or her, we create a discriminatory culture, where only perfect humans may apply for entrance. This is a powerful obstacle against equality and acceptance of the disabled, which a just society must set as its first goal.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...
Continue Reading
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue Reading
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
Top 5 Most Recently Viewed Articles
Haivision StreamHub and MoJoPro Revolutionize Mobile Broadcasting Haivision Systems Inc. (TSX: HAI), a leader in real-time video networking, has launched an innovative mobile broadcasting solution. Now available on the AWS Marketplace, the pairing of Haivision StreamHub with the MoJoPro app changes the game for journalists, video professionals, and broadcasters. They can...
Continue Reading
Keurig Dr Pepper's Strategic Acquisition Plans for JDE Peet's In a noteworthy announcement, Keurig Dr Pepper Inc. (NASDAQ: KDP) and JDE Peet's N.V. are making headlines with their plans regarding a public offer. This joint statement serves to inform stakeholders about the progress on KDP's intended recommended public offer for all outstanding shares of JDE Peet's. Basis...
Continue Reading
Join Wreaths Across America This December This December, Wreaths Across America (WAA), a national nonprofit, is gearing up for a meaningful wreath season. With over 20 new loads in need of carrier support, WAA is on the lookout for dedicated carriers and professional drivers who want to take part in its mission to Remember, Honor, and Teach. This initiative is set to...
Continue Reading
iMD Companies and Riize Health Launch New Supplements iMD Companies, Inc. (OTC: ICBU) and its subsidiary, Riize LLC, are making waves in the health sector by introducing three new non-prescription products designed for online and retail distribution. The launch is set for the first quarter of the upcoming year and aims to cater directly to consumer needs in the...
Continue Reading
Activist Investors Surge in 2024 By Svea Herbst-Bayliss A remarkable shift occurred in 2024 as a record number of activist shareholders launched campaigns aimed at global companies. Recent reports highlight that tactics employed by these shareholders have yielded impressive returns, which suggests a continued rise in these activities as we progress into the future. Rising...
Continue Reading